Dr. James J. Hickman is co-founder and Chief Scientist at Hesperos, Inc., a biotechnology CRO leveraging its' patented, Human-on-a-Chip multi-organ platforms to accelerate drug discovery by providing safety and efficacy testing for novel therapeutics. He is also a Professor of Nanoscience Technology and Electrical Engineering at the University of Central Florida and has a Ph.D. from MIT in Chemistry. Hesperos has been constructing multi-organ human-on-a-chip or body-on-a-chip systems for toxicology and efficacy with up to 6 organs and has demonstrated long-term (>28 days) evaluation of drugs and compounds, that have shown similar response to results seen from clinical data or reports in the literature. He developed the first serum-free, defined culture systems for neuronal and cardiac systems and well as other organ mimics. He is the sole or co-inventor on over 40 pending and issued U.S. and international patents, as well as over 170 publications and 20 book chapters, and has given over 254 presentations.